New pain pill HRS-6257 enters first human tests
NCT ID NCT07301333
First seen Jan 05, 2026 · Last updated May 22, 2026 · Updated 20 times
Summary
This early-stage study tests an experimental pain drug called HRS-6257 in 80 healthy volunteers aged 18-55. The main goal is to check safety and how the body processes the drug, including the effect of food. Researchers will also measure pain tolerance using a cold test. This is a first step to see if the drug is safe enough for future studies in people with pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Third Xiangya Hospital of Central South University
RECRUITINGChangsha, Hunan, 410013, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.